凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688065 凯赛生物

已收盘 08-16 15:00:00

{"stockData":{"symbol":"688065","market":"SH","secType":"STK","nameCN":"凯赛生物","latestPrice":35.99,"timestamp":1723791600000,"preClose":36.97,"halted":0,"volume":2051829,"delay":0,"floatShares":583000000,"shares":583000000,"eps":0.6379,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.98,"latestTime":"08-16 15:00:00","open":37,"high":37.09,"low":35.61,"amount":73755800,"amplitude":0.04,"askPrice":35.99,"askSize":3,"bidPrice":35.8,"bidSize":6,"shortable":0,"etf":0,"ttmEps":0.6379,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":36.97,"symbolType":"stock_kcb","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":40.67,"lowLimit":33.27,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":583378039,"pbRate":1.86,"roa":"--","roe":"2.19%","epsLYR":0.63,"committee":-0.531599,"marketValue":20996000000,"floatMarketCap":20996000000,"peRate":56.419502,"changeRate":-0.0265,"turnoverRate":0.0035,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-08-19。","afterMarket":{"amount":0,"volume":0,"close":35.99,"buyVolume":0,"sellVolume":0,"time":1723793637153,"indexStatus":"已收盘 08-16 15:30:00","preClose":36.97}},"requestUrl":"/m/hq/s/688065/tweets","defaultTab":"tweets","newsList":[{"id":"2460393279","title":"凯赛生物（688065）8月16日主力资金净卖出109.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460393279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460393279?lang=zh_cn&edition=full","pubTime":"2024-08-17 08:22","pubTimestamp":1723854128,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月16日收盘，凯赛生物报收于35.99元，下跌2.65%，换手率0.35%，成交量2.05万手，成交额7375.58万元。近5日资金流向一览见下表：凯赛生物融资融券信息显示，融资方面，当日融资买入468.71万元，融资偿还431.41万元，融资净买入37.31万元。凯赛生物主营业务：利用生物制造技术,从事新型生物基材料的研发、生产及销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081700013118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2459529838","title":"凯赛生物(688065)6月30日股东户数0.98万户，较上期增加5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459529838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459529838?lang=zh_cn&edition=full","pubTime":"2024-08-16 17:02","pubTimestamp":1723798920,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯赛生物披露，截至2024年6月30日公司股东户数为9750.0户，较3月31日增加480.0户，增幅为5.18%。在化学制品行业个股中，凯赛生物股东户数低于行业平均水平，截至6月30日，化学制品行业平均股东户数为2.62万户。户均持股市值方面，化学制品行业A股上市公司户均持股市值为28.99万元，凯赛生物高于行业平均水平。从股价来看，2024年3月31日至2024年6月30日，凯赛生物区间涨幅为2.83%，在此期间股东户数增加480.0户，增幅为5.18%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600035456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2459261672","title":"凯赛生物(688065)2024年半年报点评：24Q2业绩符合预期 净利率环比修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2459261672","media":"西部证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459261672?lang=zh_cn&edition=full","pubTime":"2024-08-16 15:39","pubTimestamp":1723793960,"startTime":"0","endTime":"0","summary":"事件：公司发布2024 年半年报，24H1 实现营收14.44 亿元，同比+40%，实现归母净利2.47 亿元，同比+2%，扣非净利2.40 亿元，同比+11%。长链二元酸销量回升支撑营收上涨，净利率环比修复。Q2 净利率环比修复。24H1 生物基聚酰胺系列贡献营业收入0.79亿元，同比增长12.61%。年产50 万吨生物基戊二胺及90 万吨生物基聚酰胺项目预计2025 年底投产，部分产能先于2024 年底建成，当前工程进度为22.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408161539259f304613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408161539259f304613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2459403073","title":"图解凯赛生物中报：第二季度单季净利润同比减22.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459403073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459403073?lang=zh_cn&edition=full","pubTime":"2024-08-16 01:33","pubTimestamp":1723743200,"startTime":"0","endTime":"0","summary":"证券之星消息，凯赛生物2024年中报显示，公司主营收入14.44亿元，同比上升40.16%；归母净利润2.47亿元，同比上升2.31%；扣非净利润2.4亿元，同比上升11.34%；其中2024年第二季度，公司单季度主营收入7.6亿元，同比上升44.72%；单季度归母净利润1.42亿元，同比下降22.9%；单季度扣非净利润1.37亿元，同比下降19.35%；负债率18.73%，投资收益-381.64万元，财务费用-7101.07万元，毛利率31.22%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600001978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065"],"gpt_icon":0},{"id":"2459044470","title":"凯赛生物(688065.SH)完成回购97.78万股 耗资5042.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459044470","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459044470?lang=zh_cn&edition=full","pubTime":"2024-08-15 18:41","pubTimestamp":1723718495,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯赛生物(688065.SH)公告，截至本公告披露之日，公司完成本次回购，已实际回购公司股份97.78万股，占公司总股本583,378,039股的比例为0.17%，回购成交的最高价为57.37元/股，最低价为36.40元/股，回购均价为51.57元/股，支付的资金总额为人民币5042.58万元(不含印花税、交易佣金等交易费用)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2459441124","title":"凯赛生物(688065.SH)发布上半年业绩，净利润1.47亿元，同比增长2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459441124","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459441124?lang=zh_cn&edition=full","pubTime":"2024-08-15 18:38","pubTimestamp":1723718292,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯赛生物 发布2024年半年度报告，公司营业收入14.44亿元，同比增长40.16%;归属于上市公司股东的净利润1.47亿元，同比增长2.31%;归属于上市公司股东的扣除非经常性损益的净利润2.4亿元，同比增长11.34%;基本每股收益0.42元/股。报告期内，公司营业收入同比上年同期数上涨40.16%,主要系公司紧抓市场机遇，加大产品销售力度，同时新产品癸二酸产能放量，因此，长链二元酸销售量，销售收入较去年同期大幅上涨。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688065"],"gpt_icon":0},{"id":"2459446726","title":"凯赛生物：业绩说明会定于8月26日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2459446726","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459446726?lang=zh_cn&edition=full","pubTime":"2024-08-15 18:04","pubTimestamp":1723716294,"startTime":"0","endTime":"0","summary":"每经AI快讯，凯赛生物 8月15日晚间发布公告称，公司2024年半年度业绩说明会定于2024年08月26日下午13:00-14:00，以上证路演中心网络互动的形式进行。2023年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比97.77%。截至发稿，凯赛生物市值为216亿元。道达号“个股趋势”提醒：1. 凯赛生物近30日内北向资金持股量减少98.26万股，占流通股比例减少0.16%；2. 近30日内无机构对凯赛生物进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151805079f2d857f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151805079f2d857f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2459446185","title":"凯赛生物最新公告：累计回购0.17%股份 公司完成本次回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2459446185","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459446185?lang=zh_cn&edition=full","pubTime":"2024-08-15 18:00","pubTimestamp":1723716028,"startTime":"0","endTime":"0","summary":"凯赛生物公告，公司于2023年8月23日至2024年8月22日期间，以集中竞价交易方式回购公司股份97.7764万股，占总股本的0.17%，回购成交最高价为57.37元/股，最低价为36.40元/股，回购均价为51.57元/股，支付的资金总额为人民币5,042.58万元。回购的股份将在未来适宜时机用于员工持股计划或股权激励。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500036502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2459723446","title":"凯赛生物(688065.SH)：上半年净利润2.47亿元，同比增长2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459723446","media":"格隆汇资讯","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459723446?lang=zh_cn&edition=full","pubTime":"2024-08-15 17:54","pubTimestamp":1723715689,"startTime":"0","endTime":"0","summary":"格隆汇8月15日丨凯赛生物(688065.SH)公布2024年半年度报告，报告期实现营业收入14.44亿元，同比增长40.16%；归属于上市公司股东的净利润2.47亿元，同比增长2.31%；归属于上市公司股东的扣除非经常性损益的净利润2.4亿元，同比增长11.34%；基本每股收益0.42元。报告期内，公司营业收入同比上年同期数上涨40.16%,主要系公司紧抓市场机遇，加大产品销售力度，同时新产品癸二酸产能放量，因此，长链二元酸销售量，销售收入较去年同期大幅上涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151754569f2d7a0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151754569f2d7a0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065"],"gpt_icon":0},{"id":"2459446729","title":"凯赛生物(688065.SH)：累计回购0.17%股份 公司完成本次回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2459446729","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459446729?lang=zh_cn&edition=full","pubTime":"2024-08-15 17:54","pubTimestamp":1723715674,"startTime":"0","endTime":"0","summary":"格隆汇8月15日丨凯赛生物(688065.SH)公布，截至本公告披露之日，公司完成本次回购，已实际回购公司股份977,764股，占公司总股本583,378,039股的比例为0.17%，回购成交的最高价为57.37元/股，最低价为36.40元/股，回购均价为51.57元/股，支付的资金总额为人民币50,425,754.38元（不含印花税、交易佣金等交易费用）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815175444959b22fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815175444959b22fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2459463282","title":"凯赛生物8月13日获融资净买入309万元 环比增加308.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459463282","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459463282?lang=zh_cn&edition=full","pubTime":"2024-08-15 10:00","pubTimestamp":1723687204,"startTime":"0","endTime":"0","summary":"8月13日，凯赛生物获融资净买入309万元，环比上一交易日增加308.67%。其中，融资买入552万元，融资偿还243万元。融券方面，融券卖出0.41万股，当前融券余量为17.25万股。A股市场共有3355股获融资净买入，凯赛生物净买入额排名第365。股市有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151000129599d785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151000129599d785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2459346163","title":"凯赛生物（688065）8月13日主力资金净卖出272.10万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459346163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459346163?lang=zh_cn&edition=full","pubTime":"2024-08-14 08:23","pubTimestamp":1723595016,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月13日收盘，凯赛生物报收于37.53元，下跌1.0%，换手率0.2%，成交量1.19万手，成交额4468.81万元。近5日资金流向一览见下表：凯赛生物融资融券信息显示，融资方面，当日融资买入552.55万元，融资偿还243.04万元，融资净买入309.51万元。凯赛生物主营业务：利用生物制造技术,从事新型生物基材料的研发、生产及销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400015176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2459133941","title":"凯赛生物获得发明专利授权：“一种奇数碳聚酰胺弹性体及其制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2459133941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459133941?lang=zh_cn&edition=full","pubTime":"2024-08-14 02:26","pubTimestamp":1723573580,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示凯赛生物新获得一项发明专利授权，专利名为“一种奇数碳聚酰胺弹性体及其制备方法”，专利申请号为CN202110992840.0，授权日为2024年8月13日。今年以来凯赛生物新获得专利授权51个，较去年同期增加了4.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400004385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2459477049","title":"凯赛生物08月13日主力资金流出225万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2459477049","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459477049?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:18","pubTimestamp":1723533517,"startTime":"0","endTime":"0","summary":"08月13日, 凯赛生物股价跌1.00%，报收37.53元，成交金额4468万元，换手率0.20%，振幅2.90%，量比0.88。凯赛生物今日主力资金净流出225万元，连续3日净流出，上一交易日主力净流出132万元，今日环比增加70.45%。该股近5个交易日下跌2.27%，主力资金累计净流出494万元；近20日主力资金累计净流出645万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131527039f26986b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131527039f26986b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2457938254","title":"凯赛生物8月6日获融资净买入373万元 环比增加246.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457938254","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457938254?lang=zh_cn&edition=full","pubTime":"2024-08-08 10:00","pubTimestamp":1723082405,"startTime":"0","endTime":"0","summary":"8月6日，凯赛生物获融资净买入373万元，环比上一交易日增加246.76%。其中，融资买入671万元，融资偿还297万元。融券方面，融券卖出0.30万股，当前融券余量为13.97万股。A股市场共有3354股获融资净买入，凯赛生物净买入额排名第428。股市有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081000109f18d3a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081000109f18d3a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2457841383","title":"凯赛生物（688065）8月7日主力资金净卖出102.50万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457841383","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457841383?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:24","pubTimestamp":1723076688,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月7日收盘，凯赛生物报收于37.78元，下跌1.61%，换手率0.22%，成交量1.28万手，成交额4866.5万元。近5日资金流向一览见下表：凯赛生物融资融券信息显示，融资方面，当日融资买入334.86万元，融资偿还224.06万元，融资净买入110.8万元，连续3日净买入累计592.48万元。凯赛生物主营业务：利用生物制造技术,从事新型生物基材料的研发、生产及销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800012629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2456490791","title":"凯赛生物（688065）8月1日主力资金净买入569.73万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456490791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456490791?lang=zh_cn&edition=full","pubTime":"2024-08-02 08:24","pubTimestamp":1722558258,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月1日收盘，凯赛生物报收于38.5元，下跌1.89%，换手率0.33%，成交量1.95万手，成交额7600.03万元。近5日资金流向一览见下表：凯赛生物融资融券信息显示，融资方面，当日融资买入699.59万元，融资偿还262.88万元，融资净买入436.71万元，连续3日净买入累计1281.06万元。凯赛生物主营业务：利用生物制造技术,从事新型生物基材料的研发、生产及销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080200012647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2455605101","title":"凯赛生物07月30日主力资金流出188万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2455605101","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455605101?lang=zh_cn&edition=full","pubTime":"2024-07-30 15:25","pubTimestamp":1722324331,"startTime":"0","endTime":"0","summary":"07月30日, 凯赛生物股价跌0.78%，报收38.25元，成交金额5317万元，换手率0.24%，振幅2.39%，量比1.21。凯赛生物今日主力资金净流出188万元，连续3日净流出，上一交易日主力净流出664万元，今日环比减少71.69%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为63.16%，平均跌幅为1.04%。该股近5个交易日下跌3.19%，主力资金累计净流出1348万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2832万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730153359956ba47d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730153359956ba47d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2455623682","title":"北向资金7月29日净卖出凯赛生物0.58万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2455623682","media":"自选股智能写手","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455623682?lang=zh_cn&edition=full","pubTime":"2024-07-30 09:30","pubTimestamp":1722303035,"startTime":"0","endTime":"0","summary":"7月29日，北向资金减持凯赛生物0.58万股连续5日减持。截止当日收盘，沪股通共持有凯赛生物510.32万股，占流通股0.87%。沪股通减持金额前五个股分别为贵州茅台、药明康德、工业富联、中远海控、韦尔股份。凯赛生物近5个交易日下跌5.28%，沪股通累计减持39.31万股；近20个交易日下跌15.74%，沪股通累计减持109.55万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730093508956a0121&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730093508956a0121&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":1},{"id":"2455250822","title":"凯赛生物7月26日获融资净买入347万元 环比增加1176.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455250822","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455250822?lang=zh_cn&edition=full","pubTime":"2024-07-29 10:00","pubTimestamp":1722218405,"startTime":"0","endTime":"0","summary":"7月26日，凯赛生物获融资净买入347万元，环比上一交易日增加1176.58%。其中，融资买入643万元，融资偿还295万元。融券方面，融券卖出1.17万股，当前融券余量为31.22万股。A股市场共有1599股获融资净买入，凯赛生物净买入额排名第138。股市有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407291000149ef42448&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407291000149ef42448&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-12","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路1690号5幢4楼","stockEarnings":[{"period":"1week","weight":-0.0544},{"period":"1month","weight":-0.1128},{"period":"3month","weight":-0.293},{"period":"6month","weight":-0.2501},{"period":"1year","weight":-0.4044},{"period":"ytd","weight":-0.3423}],"companyName":"上海凯赛生物技术股份有限公司","boardCode":"AI0028","perCapita":"59833股","boardName":"化学纤维制造业","registeredCapital":"58337万元","compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0282},{"period":"3month","weight":-0.0871},{"period":"6month","weight":0.0047},{"period":"1year","weight":-0.0899},{"period":"ytd","weight":-0.0321}],"survey":"　　上海凯赛生物技术股份有限公司从事新型生物基材料的研发、生产及销售。公司目前主要产品为生物法长链二元酸系列产品、生物基聚酰胺及单体产品等。公司重视打造技术竞争力，坚持走自主创新的发展道路，截至报告期末公司拥有318项发明专利在内的406项专利，获得国际纺织制造商联合会（ITMF）颁发的“《可持续与创新奖》（SUSTAINABILITY&INNOVATION）”，被认定为“国家企业技术中心”、“国家级第三批专精特新‘小巨人’企业”、“国家知识产权局优势企业”。","serverTime":1723894508172,"listedPrice":133.45,"stockholders":"9750人(较上一季度增加5.18%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯赛生物,688065,凯赛生物股票,凯赛生物股票老虎,凯赛生物股票老虎国际,凯赛生物行情,凯赛生物股票行情,凯赛生物股价,凯赛生物股市,凯赛生物股票价格,凯赛生物股票交易,凯赛生物股票购买,凯赛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}